Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profound Medical Corp (TSX:PRN)

8.600 +0.030 (+0.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Profound Medical Corp

< Previous 1 2 3 Next >
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
Clinical validation from the Busch Center highlights the proven, scalable innovation driving a paradigm shift in prostate care — delivering precision treatment and better patient outcomes 
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
To release full third quarter 2025 financial results on November 13th; conference call to follow 
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Second Quarter 2025 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
New program delivers TULSA Procedure’s precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas 
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
From Profound Medical Corp.
Via GlobeNewswire
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces First Quarter 2025 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical AUA 2025 Investor Event Agenda
From Profound Medical Corp.
Via GlobeNewswire
Save the Date: Profound Medical to Host Investor Event at AUA 2025
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Proposed Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’
TULSA procedure’s unrivaled flexibility, real-world efficacy and ongoing CAPTAIN post-market study to be featured in the scientific programs at the upcoming RSNA and SUO meetings 
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Third Quarter 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.